Tesla Is Transitioning For Industry 4.0 (Rating Upgrade)
Tesla, Inc. stock faces short-term challenges but holds strong long-term potential with its robotaxi program and robotics ...
Tariffs Aren't As Scary For Tesla: Upgrading To Strong Buy
Tesla is well-positioned amid tariff wars with the new Model Y and FSD. Learn why TSLA stock is upgraded from buy to strong ...
The Harvard Crimson1d
FDA Layoffs, Funding Cuts Cast Shadow Over Biopharma Industry
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...
Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico
Alcohol Detoxification and Anti-Hangover Beverage (Available on amazon.com and unbuzzd.com) to be Distributed by FUSION in ...
FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
Trump’s Tariffs Could Blow Up Big Pharma’s Tax Shelter
Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...
Winners and wishers: 9 potential Bay Area drug approvals coming this year
Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...
Fierce Pharma3d
Axsome's Sunosi comes up short in trial but shows promise in treating MDD with daytime sleepiness
A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...
Investornewsbreaks Quantum Biopharma Ltd. (NASDAQ: QNTM) Partners With Mass General On PET Imaging Study For Multiple Sclerosis
Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusett ...
Fresenius’ Misconduct Defense Fails in PharmaSphere Patent Case
A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
Investornewsbreaks Quantum Biopharma Ltd. (NASDAQ: QNTM) Closes $5 Million Offering To Advance Drug Development
Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company, announced the closing of its final tranche in a debenture unit offering, raising a tot ...
Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms
In addition, the Company has begun development of a formulation for rekvry™ – an alcohol misuse treatment for emergency and hospital settings. The Company believes that rekvry™ fulfills an unmet need ...